To access all features and enjoy the full functionality of this site, please ensure your browser is up-to-date. For IE8 users, the most recent version is IE11.

TECNIS Odyssey™ IOL

TECNIS

Odyssey IOL

 

Precise vision. Every distance.

Any lighting.*

 

Enhanced Tolerance to Refractive Error**,1   Optimized Dysphotopsia Profile***,2   Remarkable range of vision†,3   Best-in-Class Contrast††,4  
Enhanced Tolerance to Refractive Error**,1
Optimized Dysphotopsia Profile***,2
Remarkable range of vision†,3
Best-in-Class Contrast††,4

 

Delivering

Remarkable Patient

Satisfactionˆ

94%

Satisfaction with overall vision
without glasses.^^,5

 

96%

Satisfaction with reading on a
smartphone or tablet.^^,8

 

92%

Satisfaction with ability to see steps
and curbs at night.^^,8

Optimized Dysphotopsia Profile***,2

 

Freeform diffractive profile contributes to a low incidence
of bothersome visual disturbances.^,^^^,6

 

93% reported none or mild halos, glare or starbursts at one month post-op^,^^^,6

FOOTNOTES
*DFU/Instructions for use Z311982E, current version
** Compared to TECNIS Synergy™ OptiBlue™ based on simulation in physiological eye models
***Compared to TECNIS Synergy™ OptiBlue™ based on bench testing
† Based on bench testing.
†† Based on bench testing
^ Values rounded to the nearest 1%
^^ Based on 3-month postoperative data from a multicenter, observational clinical study in the U.S.
^^^ Retrospective, multi-center, real-world clinical analysis of reported outcomes at 1 month post-operative visit, n=96. Symptoms reported without a specified severity level were classified as mild in the chart above.

 

REFERENCES
1.2024DOF4003 - Simulated tolerance to refractive error
2.2024DOF4005 - Laboratory measurement of intensity of extended objects for halo
3.DOF2023CT4023 – Simulated Visual Acuity data.
4.DOF2023CT4007, 2024DOF4033, DOF2019OTH4002, 2025DOF4003, 2025DOF4006 - Contrast (MTF) measurements
5.2024DOF4027 – User Acceptability Evaluation of Pseudophakic Patients Previously Implanted with the TECNIS Odyssey™ IOL. PATIENT REPORTED SPECTACLE INDEPENDENCE QUESTIONNAIRE (PRSIQ). 11 Jun 2024
6.DOF2023CT4050 is clinical outcomes in the RWD study.
7.2024DOF4002 - TECNIS Odyssey Full Visual Range IOL
8.2024DOF4029 - User Acceptability Evaluation of Pseudophakic Patients Previously Implanted with the TECNIS Odyssey™ IOL. Low Light Vision Questionnaire Outcomes. 11 June 2024.

 

 

For healthcare professionals only. Please reference the Instructions for Use for a complete list of Indications and Important Safety Information and contact our specialists in case of any question.

 

©Johnson & Johnson and its affiliates 2025. All rights reserved.

2024PP17394v2